These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 24805287)

  • 21. PEG conjugated VEGF siRNA for anti-angiogenic gene therapy.
    Kim SH; Jeong JH; Lee SH; Kim SW; Park TG
    J Control Release; 2006 Nov; 116(2):123-9. PubMed ID: 16831481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of cellular uptake and gene transfer efficiency of pegylated poly-L-lysine compacted DNA: implications for cancer gene therapy.
    Walsh M; Tangney M; O'Neill MJ; Larkin JO; Soden DM; McKenna SL; Darcy R; O'Sullivan GC; O'Driscoll CM
    Mol Pharm; 2006; 3(6):644-53. PubMed ID: 17140252
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of cell-penetrating peptide-modified MPEG-PCL diblock copolymeric nanoparticles for systemic gene delivery.
    Tanaka K; Kanazawa T; Shibata Y; Suda Y; Fukuda T; Takashima Y; Okada H
    Int J Pharm; 2010 Aug; 396(1-2):229-38. PubMed ID: 20600726
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reversible PEGylation and Schiff-base linked imidazole modification of polylysine for high-performance gene delivery.
    Cai X; Li Y; Yue D; Yi Q; Li S; Shi D; Gu Z
    J Mater Chem B; 2015 Feb; 3(8):1507-1517. PubMed ID: 32262423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complexation of Chol-DsiRNA in place of Chol-siRNA greatly increases the duration of mRNA suppression by polyplexes of PLL(30)-PEG(5K) in primary murine syngeneic breast tumors after i.v. administration.
    Ambardekar VV; Wakaskar RR; Ye Z; Curran SM; McGuire TR; Coulter DW; Singh RK; Vetro JA
    Int J Pharm; 2018 May; 543(1-2):130-138. PubMed ID: 29601972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Filamentous condensation of DNA induced by pegylated poly-L-lysine and transfection efficiency.
    Stanić V; Arntz Y; Richard D; Affolter C; Nguyen I; Crucifix C; Schultz P; Baehr C; Frisch B; Ogier J
    Biomacromolecules; 2008 Jul; 9(7):2048-55. PubMed ID: 18572920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histidinylated poly-L-lysine-based vectors for cancer-specific gene expression via enhancing the endosomal escape.
    Zhao GX; Tanaka H; Kim CW; Li K; Funamoto D; Nobori T; Nakamura Y; Niidome T; Kishimura A; Mori T; Katayama Y
    J Biomater Sci Polym Ed; 2014; 25(5):519-34. PubMed ID: 24460548
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histidylated polylysine as DNA vector: elevation of the imidazole protonation and reduced cellular uptake without change in the polyfection efficiency of serum stabilized negative polyplexes.
    Bello Roufaï M; Midoux P
    Bioconjug Chem; 2001; 12(1):92-9. PubMed ID: 11170371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of polymeric endosomolytic agents in gene transfection: a comparative study of poly(L-lysine) grafted with monomeric L-histidine analogue and poly(L-histidine).
    Hwang HS; Hu J; Na K; Bae YH
    Biomacromolecules; 2014 Oct; 15(10):3577-86. PubMed ID: 25144273
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytoplasm-responsive nanocarriers conjugated with a functional cell-penetrating peptide for systemic siRNA delivery.
    Tanaka K; Kanazawa T; Horiuchi S; Ando T; Sugawara K; Takashima Y; Seta Y; Okada H
    Int J Pharm; 2013 Oct; 455(1-2):40-7. PubMed ID: 23911914
    [TBL] [Abstract][Full Text] [Related]  

  • 31. cRGD-functionalized mPEG-PLGA-PLL nanoparticles for imaging and therapy of breast cancer.
    Liu P; Qin L; Wang Q; Sun Y; Zhu M; Shen M; Duan Y
    Biomaterials; 2012 Oct; 33(28):6739-47. PubMed ID: 22763223
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Self-assembled carboxymethyl poly (L-histidine) coated poly (β-amino ester)/DNA complexes for gene transfection.
    Gu J; Wang X; Jiang X; Chen Y; Chen L; Fang X; Sha X
    Biomaterials; 2012 Jan; 33(2):644-58. PubMed ID: 22030282
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
    Li TS; Yawata T; Honke K
    Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PEG-detachable cationic polyaspartamide derivatives bearing stearoyl moieties for systemic siRNA delivery toward subcutaneous BxPC3 pancreatic tumor.
    Kim HJ; Oba M; Pittella F; Nomoto T; Cabral H; Matsumoto Y; Miyata K; Nishiyama N; Kataoka K
    J Drug Target; 2012 Jan; 20(1):33-42. PubMed ID: 22066783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lactose-poly(ethylene glycol)-grafted poly-L-lysine as hepatoma cell-tapgeted gene carrier.
    Choi YH; Liu F; Park JS; Kim SW
    Bioconjug Chem; 1998; 9(6):708-18. PubMed ID: 9815164
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PEGylated PEI-based biodegradable polymers as non-viral gene vectors.
    Huang FW; Wang HY; Li C; Wang HF; Sun YX; Feng J; Zhang XZ; Zhuo RX
    Acta Biomater; 2010 Nov; 6(11):4285-95. PubMed ID: 20601231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chitosan-graft-(PEI-β-cyclodextrin) copolymers and their supramolecular PEGylation for DNA and siRNA delivery.
    Ping Y; Liu C; Zhang Z; Liu KL; Chen J; Li J
    Biomaterials; 2011 Nov; 32(32):8328-41. PubMed ID: 21840593
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppression of growth of pancreatic cancer cell and expression of vascular endothelial growth factor by gene silencing with RNA interference.
    Wang J; Shi YQ; Yi J; Ye S; Wang LM; Xu YP; He M; Kong XM
    J Dig Dis; 2008 Nov; 9(4):228-37. PubMed ID: 18959596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prostate cancer cell-specific VEGF siRNA delivery system using cell targeting peptide conjugated polyplexes.
    Kim SH; Lee SH; Tian H; Chen X; Park TG
    J Drug Target; 2009 May; 17(4):311-7. PubMed ID: 19242850
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of endosomal escape peptides on in vitro gene delivery of polyethylene glycol-based vehicles.
    Moore NM; Sheppard CL; Barbour TR; Sakiyama-Elbert SE
    J Gene Med; 2008 Oct; 10(10):1134-49. PubMed ID: 18642401
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.